Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low molecular weight heparins

D Bergqvist1

  • 1Department of Surgery, University Hospital, Uppsala, Sweden.

Journal of Internal Medicine
|August 1, 1996
PubMed
Summary

Low molecular weight heparins (LMWHs) offer improved bioavailability and longer half-life compared to unfractionated heparin (UFH), allowing once-daily dosing without monitoring. LMWHs demonstrate superior efficacy and safety for preventing venous thromboembolism and treating deep vein thrombosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cranial nerve injuries after carotid artery surgery. A prospective study of 663 operations.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·1995
Same author

[Arterial surgery of the extremities without angiography. A simpler preoperative survey with color doppler].

Lakartidningen·1995
Same author

The haemorrhagic effect of low molecular weight heparins, dermatan sulphate and hirudin.

Haemostasis·1995
Same author

Intraplaque haemorrhage at carotid artery surgery--a predictor of cardiovascular mortality.

Journal of internal medicine·1995
Same author

[Vascular surgeons make comparison with the USA. Low level of Swedish control over implants].

Lakartidningen·1995
Same author

Reduction of requirement for leg vascular surgery during long-term treatment of claudicant patients with ticlopidine: results from the Swedish Ticlopidine Multicentre Study (STIMS).

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·1995

Area of Science:

  • Pharmacology
  • Biochemistry
  • Clinical Medicine

Background:

  • Low molecular weight heparins (LMWHs) are derived from unfractionated heparin (UFH) but possess distinct molecular weight distributions.
  • These differences influence their pharmacokinetic and pharmacodynamic properties, leading to potential clinical advantages over UFH.

Purpose of the Study:

  • To compare the clinical efficacy and safety of LMWHs versus UFH.
  • To evaluate the suitability of LMWHs for various therapeutic applications, including prophylaxis and treatment of thromboembolic disorders.

Main Methods:

  • The study is a review of existing clinical research and literature comparing LMWHs and UFH.
  • Key parameters assessed include bioavailability, half-life, dosing frequency, monitoring requirements, efficacy in thromboembolism prophylaxis and treatment, and adverse event profiles.

Main Results:

  • LMWHs exhibit superior subcutaneous bioavailability and a longer biological half-life than UFH, enabling once-daily administration without the need for routine monitoring.
  • LMWHs are more effective than UFH in preventing postoperative venous thromboembolism and offer comparable or improved safety profiles with less bleeding.
  • LMWHs are also favorably compared to UFH for initiating deep vein thrombosis treatment and as anticoagulants during hemodialysis.
  • Adverse effects like thrombocytopenia and osteoporosis are less common with LMWHs than with UFH.

Conclusions:

  • LMWHs represent a clinically advantageous alternative to UFH for prophylaxis and treatment of venous thromboembolic events.
  • Further research is necessary to establish the role of LMWHs in managing arterial diseases due to limited current evidence.

Related Experiment Videos